NUP98 and leukemia: In KMT2A‐ as well as NUP98‐rearranged leukemia unbiased CRISPR‐Cas9 screens have revealed that loss of PRC1.1 function renders leukemia cells resistant to Menin inhibition.108, 110, 111, 112